Coenzyme Q10 as a therapeutic candidate for treating inherited photoreceptor degeneration by Zhang, Xun et al.
Coenzyme Q10 as a potential therapeutic candidate for treating inherited
photoreceptor degeneration










Link to publication in ResearchOnline
Citation for published version (Harvard):
Zhang, X, Biswas, L, Tohari, AM, Reilly, J, Tiano, L & Shu, X 2017, 'Coenzyme Q10 as a potential therapeutic
candidate for treating inherited photoreceptor degeneration', Neural Regeneration Research, vol. 12, pp. 1979-
1981. https://doi.org/10.4103/1673-5374.221152
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please view our takedown policy at https://edshare.gcu.ac.uk/id/eprint/5179 for details
of how to contact us.
Download date: 29. Apr. 2020
1 
 
Coenzyme Q10 as a potential therapeutic candidate for treating inherited photoreceptor 1 
degeneration 2 
Xun Zhang1, Lincoln Biswas1. Ali Mohammad Tohari1, James Reilly1, Luca Tiano2, Xinhua Shu1* 3 
1 Department of Life Sciences, Glasgow Caledonian University, Glasgow G4 0BA, UK 4 
2 Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, 5 
Italy 6 
Inherited photoreceptor degeneration 7 
      The human retina is a highly specialised tissue that enables the perception of light across a range 8 
of intensities and colours. It covers about 65% of the inner surface of the eye and contains three 9 
layers of cells: the outer nuclear layer (ONL) containing the cell bodies and nuclei of the light-10 
sensitive rod and cone photoreceptors whose photopigment-containing outer segments form the 11 
photoreceptor layer; the inner nuclear layer (INL) containing bipolar, horizontal and amacrine cells; 12 
and the ganglion cell layer (GCL) from which the the optic nerve arises. There are two layers of 13 
synaptic connections between these three layers: the photoreceptors synapse with second order 14 
neurons, mainly bipolar cells, in the outer plexiform layer (OPL), while in turn the bipolar cells form 15 
connections in the inner plexiform layer (IPL) with ganglion cells. The retinal pigment epithelium 16 
(RPE) lies directly behind the photoreceptor layer, is heavily pigmented to reduce scattering of light, 17 
and is essential for the nourishment, maintenance and metabolism of photoreceptors. 18 
      Inherited photoreceptor degeneration (IPD), usually referred to as monogenic retinal disease, is 19 
characterised by the dysfunction or death of photoreceptor cells (Bramall et al., 2010).  IPD has a 20 
large degree of genotypic and phenotypic heterogeneity. Currently, 261 genes and 298 loci have 21 
been reported to be associated with IPD (Retinal Information Network, accessed 16 November 2017, 22 
<https://sph.uth.edu/RetNet/>). IPD associated genes function in a wide range of biological 23 
processes, including photoreceptor cell development and maintenance, phototransduction, ciliary 24 
trafficking, phagocytosis, protein quality control, and metabolism (Bramall et al., 2010). Clinical 25 
features in IPD can be classified into rod dystrophy, cone dystrophy, and rod-and-cone dystrophy, 26 
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depending on which type of photoreceptor cells are initially affected. Photoreceptor cell death in IPD 1 
is mainly through caspase-dependent and caspase-independent apoptosis, though necrosis is also 2 
reported to be involved (Bramall et al., 2010). Both oxidative stress and inflammation play a critical 3 
role in the death of photoreceptor cells.   4 
 5 
Oxidative stress in inherited photoreceptor degeneration 6 
      Oxidative stress reflects an imbalance between the production of free radicals and their 7 
counteraction by the antioxidant defence system (Wright et al., 2004). Photoreceptor cells consume 8 
oxygen at possibly the highest rate in the body, producing extremely large quantities of reactive 9 
oxygen and nitrogen species (RONS) and subsequently causing oxidative damage to macromolecules 10 
such as nucleic acids, proteins and lipids (Zhang et al., 2017). Previously we investigated oxidative 11 
stress in the retinae of four IPD mouse models (Rho-/-, Prph2rds/rds, Pde6brd1/rd1 and Pde6batrd1/atrd1) and 12 
found that they had significantly decreased activities of mitochondrial complex I compared to that of 13 
wildtype retinae, an effect that would have been compounded by the consequent increased 14 
production of reactive oxygen species (ROS) by the mitochondria. Rho-/- and Pde6brd1/rd1 mouse 15 
retinae also had markedly lower levels of the reduced form of the antioxidant glutathione (GSH) 16 
(Vlachantoni et al., 2011). Patients with retinitis pigmentosa, a common IPD, exhibited ocular 17 
oxidative damage with significantly reduced total antioxidant capacity and a reduced ratio of GSH to 18 
GSSG (the oxidised form of glutathione) in the aqueous humour compared to that of controls 19 
(Campochiaro et al., 2015). A mix of antioxidants (α-tocopherol, ascorbic acid, α-lipoic acid and 20 
Mn(III)tetrakis (4-benzoic acid) porphyrin) significantly reduced cone death and preserved cone 21 
function in an IPD mouse model (rd1), possibly through inhibiting oxidative damage (Komeima et al., 22 
2006). Co-expression of catalase and SOD2 in the photoreceptor cells of an IPD mouse model (rd10) 23 
significantly reduced superoxide radicals and carbonyl contents, decreased cone cell death, and 24 
preserved cone function (Usui et al., 2009).  25 
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      Light exposure also generates RONS and this makes photoreceptor cells vulnerable to oxidative 1 
damage. Accumulated evidence demonstrates that light damage to photoreceptors is due to the 2 
accumulation of all-trans retinal released from photo-activated rhodopsin, particularly when the 3 
recycling of all-trans retinal to 11-cis retinal is blocked due to genetic mutations. All-trans retinal 4 
molecules can form toxic bis-retinoids, such as N-retinylidene-N—retinylethanolamine (A2E), which 5 
accumulate in the RPE cells through phagocytosis (Organisciak & Vaughan, 2010). Most components 6 
of bis-retinoids are able to produce RONS when undergoing photo-oxidation.  Synthetic antioxidants 7 
such as dimethylthiourea have been shown to protect photoreceptors from light-induced damage, 8 
functioning as a quencher of free radicals. Natural products also demonstrate a protective role 9 
against light-induced retinal damage: some substances act directly as antioxidants, while others are 10 
involved in up-regulation of antioxidant gene expression.            11 
 12 
Microglia l activation in inherited photoreceptor degeneration 13 
      Microglia are a type of macrophage resident in the nervous system including the brain and retina. 14 
In the developing retina, microglia precursors may move from retinal vascular vessels and the ciliary 15 
body into the retina. After entering the retina, these precursors move along the axon fascicles to 16 
their final location in the retina. Microglia ultimately settle in the plexiform layers of the retina 17 
where their development completes. They exhibit a ramified form, constantly moving to surveille 18 
the retinal neurons. The cellular markers and receptors of microglia indicate the status of microglia 19 
(i.e. inactive or active form). These cell surface receptors also provide microglia with special immune 20 
functions. Microglia have a phagocytic role in engulfing presynaptic inputs. This function depends on 21 
microglia-specific phagocytic signalling pathway, complement receptor 3 (CR3)/C3. Under healthy 22 
conditions, microglia fulfil specialized immune tasks by releasing cytokines and neurotrophic factors. 23 
A typical interaction between microglia and neurons is the FKN/CX2CR1 system (fractalkine or 24 
CX3CL1 and its G protein- coupled receptor, CX3CR1). CX3CL1 is a chemokine in the form of a 25 
membrane-bound protein, which can bind to CX3CR1 on microglia and which modulates the 26 
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activation of microglia (Vecino et al., 2016). CX3CR1 signalling in retinal microglia plays an important 1 
role in controlling motility of the thin microglial process that continuously monitor the 2 
microenvironment in the healthy retina. Following retinal damage or a change in its condition (such 3 
as inflammation, light injury or genetic defects), microglia become activated and change their 4 
morphology, with expression of surface markers such as complement receptor, MHC-II, and CD68. 5 
Subsequently, activated microglia exhibit amoeboid movement and enter the photoreceptor layer to 6 
carry out phagocytosis (Karlstetter et al., 2015).  7 
      Activated microglia may play a pathological role in the degenerating photoreceptor layer by 8 
releasing neurotoxic factors, such as TNF-α and IL-1β. In IPD, evidence that the dying rods may 9 
attract the resting microglia to mediate phagocytosis in retinitis pigmentosa patients was first 10 
presented by Gupta. (2003). Activated microglia were found in the region of dying rods and it was 11 
proposed that the initial rod cell death further triggers the onset of cone death. In the widely used 12 
rd1 mouse model which contains nonsense mutation in PDE6b gene, activated microglia were 13 
detected from postnatal day 12 in the outer nuclear layer with releasing cytokines (such as TNF-α) 14 
and chemokines C-C motif ligand 2 (CCL2), C-C motif ligand 5 (CCL5) and monocyte chemoattractant 15 
protein 1 (MCP1) (Karlstetter et al., 2015). Similarly, in rd10 mouse, the rod degeneration is 16 
accompanied by infiltration of microglia. The dying rods exhibited the “eat me” signal PtdSer on the 17 
cell surface to induce the invasion of activated microglia into the ONL. Genetic ablation of retinal 18 
microglia significantly reduced rod cell death in rd10 mice (Zhao et al., 2015). Inhibition of microglia 19 
activation by minocycline also protected photoreceptor cells from apoptosis in IPD mouse models 20 
rds and rd10 (Bramall et al., 2010; Peng et al., 2014). Given this evidence, activated microglia-21 
mediated phagocytosis appears to be the underlying cell death mechanism contributing to retinal 22 
degeneration in IPD. 23 
 24 
Coenzyme Q10 protects retinal cells from oxidative stress and inhibits retinal microglia activation  25 
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      Coenzyme Q10 (CoQ10) is a vitamin-like molecule that is endogenously synthesized in all aerobic 1 
organisms, existing as oxidized (ubiquinone), partially reduced (semiquinone) and reduced form 2 
(ubiquinol) within the body. The lipophilic molecule plays a central role in cellular growth and 3 
metabolism through the electron transport chain where it functions as an electron acceptor, 4 
collecting electrons from mitochondrial respiratory chain complex I and complex II, then shuttling 5 
them to complex III. Additionally, CoQ10 plays a role as an antioxidant, acting as a free radical 6 
scavenger and so protecting cells from oxidative damage. It is particularly abundant in tissues that 7 
are highly oxygen-demanding, such as cardiac muscle. Although present in the retina, levels are 8 
comparatively low relative to other tissues dependent on oxidative metabolism. Following a peak in 9 
the third decade of life, the level of CoQ10 declines with age due to decreased synthesis and 10 
increased degradation. CoQ10 supplementation has been shown to slow the progression of age-11 
related neurodegenerative diseases, such as Parkinson’s disease and age-related macular 12 
degeneration (Zhang et al., 2017).  13 
      Previous work demonstrated that CoQ10 treatment protected RGC-5 cells (a rat ganglion cell 14 
line) from oxidative damage caused by exposure to H2O2, antimycin (mitochondria complex III 15 
inhibitor), radiation, or serum starvation (Zhang et al., 2017). We have also treated human retinal 16 
pigment epithelium cells (ARPE-19) with H2O2 only or with H2O2 and CoQ10, and found that cell 17 
viability was significantly increased in ARPE-19 cell exposure to CoQ10 and H2O2 when compared to 18 
cells exposed to H2O2 alone (data not shown). In addition, inflammatory cytokines such as IL-1β were 19 
markedly decreased and expression of antioxidant genes (e.g. SOD1) was notably increased in ARPE-20 
19 cells co-exposed to CoQ10 and H2O2 when compared to cells treated with H2O2 only (data not 21 
shown). 22 
      Senescence accelerated P8 (SAMP8) mice have high levels of protein oxidation and lipid 23 
peroxidation in examined tissues, demonstrate some pathological features similar to those 24 
presented in age-related neurodegenerative diseases, and have been widely used as a model for 25 
oxidative stress and ageing diseases (Morley, et al., 2012). To investigate the effect of CoQ10 on 26 
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retinal microglial activation, we treated SAMP8 mice with CoQ10 via oral administration (500mg/kg, 1 
daily) over a two-month period. We found that microglia migrated into the inner portion of the ONL 2 
in untreated SAMP8 mice, while microglia were settled in the OPL in CoQ10-treated SAMP8 mice. 3 
We also observed that expression of inflammatory cytokine IL-1β in the OPL was noticeably 4 
increased in untreated SAMP8 mice when compared to CoQ10-treated mice (Figure 1). 5 
 6 
Future directions 7 
Although CoQ10 supplement treatment shows protective effects in age-related neurodegenerative 8 
diseases and inhibits oxidative damage, inflammation and microglia activation in retina cell lines and 9 
SAMP8 retinae, more pre-clinical studies in IPD animal models are needed before it can be used 10 
effectively in a therapeutic setting. Mutations in the RPGRIP1 gene can cause Leber congenital 11 
amaurosis (LCA), juvenile retinitis pigmentosa (RP) and cone-rod dystrophy (common types of IPD) in 12 
humans. Recently, we characterized a zebrafish IPD model that carries a nonsense mutation in the 13 
RPGRIP1 gene (Raghupathy et al., in press). RPGRIP1 mutant zebrafish did not develop 14 
photoreceptor outer segments and displayed mislocalization of rhodopsin, early rod degeneration 15 
and subsequently cone degeneration (Figure 2) (Raghupathy et al., in press), similar to clinical 16 
features presented in LCA and juvenile RP patients. The potential for delaying photoreceptor cell 17 
death by CoQ10 can be evaluated in this IPD zebrafish. More evaluation may be needed in other 18 
mouse IPD models. Based on the preclinical data, clinical trial can be carried out in IPD patients. In 19 
conclusion, CoQ10 has the capacity to inhibit oxidative stress, decrease inflammation and suppress 20 
microglia activation, which will offer potential therapy for IPD patients.  21 
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Figures and legends 1 
 2 
Figure 1 CoQ10 treatment blocked microglia migration to outer nuclear layer (ONL) and suppressed 3 
inflammation. Untreated and CoQ10-treated SAMP8 mouse eyes were subjected to cryosection and 4 
immunostaining with anti-Iba-1 antibody (labelling microglia) and anti-IL-1β antibody. In untreated 5 
(No Q10) SAMP8 mouse retina, microglia (arrowheads in left-hand boxes) migrated into the inner 6 
portion of ONL; in CoQ10 treated (Q10) SAMP8 retina, microglia stayed in the outer plexiform layer 7 
(OPL). Expression of inflammatory cytokine IL-1β (arrowheads in right-hand boxes), was noticeably 8 









Figure 2 RPGRIP1-/- zebrafish displayed mislocalization of rhodopsin, early rod degeneration and 2 
subsequent cone degeneration. Eyes from both wildtype and RPGRIP1 mutant zebrafish at 14 days 3 
(14dpf) and 6 months old (6mpf) were subjected to cryosection and immunostaining using 4D2 4 
antibody (labelling rod outer segments, ROS), mislocalization of rhodopsin was seen in mutant retina 5 
at 14dpf, while rod cells showed early signs of degeneration. All rod cells in mutant retina were 6 
degenerated at 6mpf.  Zebrafish have long cones (red and green cones) and short cones (blue and 7 
UV cones), methylene blue staining showed that only short cones remained in the retina of 13mpf 8 
RPGRIP1 mutant zebrafish. GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear 9 
layer; RPE, retinal pigment epithelium. 10 
